L. Hagberg

Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid – the Gothenburg HIV CSF Study Cohort
20238 citationsauthor #1
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
20234 citationsauthor #4
The effect of vitamin B supplementation on neuronal injury in people living with HIV: a randomized controlled trial
20222 citationsauthor #2
Blood biomarkers for HIV infection with focus on neurologic complications—A review
20226 citationsauthor #1
Longitudinal Modeling Of Early Hiv Burden In The Central Nervous System
20220 citationsauthor #3
Increased immune activation and signs of neuronal injury in HIV-negative people on preexposure prophylaxis
202112 citationsauthor #4
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression
202141 citationsauthor #10
Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study
20217 citationsauthor #8
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance
202017 citationsauthor #1
CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms
202068 citationsauthor #5
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
20190 citationsauthor #6
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
201933 citationsauthor #6
Diagnosis of Lyme neuroborreliosis
20190 citationsauthor #1
Factors associated with blood culture positivity in patients with complicated skin and skin structure infection—a population-based study
201910 citationsauthor #3
Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
201831 citationsauthor #3
Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment
201847 citationsauthor #6
A potential benefit from infectious disease specialist and stationary ward in rational antibiotic therapy of complicated skin and skin structure infections
20183 citationsauthor #2
Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy
201810 citationsauthor #2
Smoking in pregnant women diagnosed with ADHD – A nationwide population- based study
20180 citationsauthor #3
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)
201714 citationsauthor #5
Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy
201762 citationsauthor #3
No support for premature CNS aging in HIV when measured by cerebrospinal fluid hyperphosphorylated tau (p-tau)
20170 citationsauthor #5
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls
2017148 citationsauthor #3
Microbiological Etiology and Treatment of Complicated Skin and Skin Structure Infections in Diabetic and Nondiabetic Patients in a Population-Based Study
201711 citationsauthor #2
Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection
20168 citationsauthor #2
Blood–brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV
201649 citationsauthor #3
Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
201667 citationsauthor #3
Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden.
201619 citationsauthor #2
Corrigendum to: “Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study” [EBioMedicine 3 (216) 135–140]
20168 citationsauthor #6
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
201629 citationsauthor #7
articleNeuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
20150 citationsauthor #7
Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study.
20155 citationsauthor #6
[Scrap the Centor criteria in tonsillitis].
20151 citationsauthor #3
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
2015443 citationsauthor #6
Association between plasma homocysteine levels and signs of axonal injury in untreated HIV
20150 citationsauthor #2
Time window for positive cerebrospinal fluid broad-range bacterial PCR and Streptococcus pneumoniae immunochromatographic test in acute bacterial meningitis
201532 citationsauthor #3
ReviewCerebrospinal fluid neopterin : an informative biomarker of central nervous system immune activation in HIV-1 infection
20150 citationsauthor #1
The Importance Of Measuring Cerebrospinal Fluid Biomarkers In Cardiac Arrest Survivors (P1.101)
20140 citationsauthor #6
Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection
2014110 citationsauthor #6
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
20141 citationsauthor #7
Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation.
201425 citationsauthor #7
An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.
201449 citationsauthor #3
Distinct Inflammatory Mediator Patterns Characterize Infectious and Sterile Systemic Inflammation in Febrile Neutropenic Hematology Patients
20148 citationsauthor #2
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
201443 citationsauthor #7
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections.
201426 citationsauthor #8
Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
2014163 citationsauthor #4
Cerebrospinal fluid biomarkers in cardiac arrest survivors.
201428 citationsauthor #6
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.
2013164 citationsauthor #12
Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection
20133 citationsauthor #6
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
20132 citationsauthor #6
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
201359 citationsauthor #8
Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections
201365 citationsauthor #2
Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders.
201364 citationsauthor #4
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
201368 citationsauthor #6
Progressive Increase in Cerebrospinal Fluid (CSF) Neopterin and Relation to Neuropsychological Performance during Primary HIV-1 Infection Prior to Antiretroviral Therapy (P06.189)
20130 citationsauthor #9
Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection
201345 citationsauthor #6
Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections
201393 citationsauthor #5
Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy
201220 citationsauthor #3
Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy)
201149 citationsauthor #2
The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis.
201113 citationsauthor #12
Reply to Seligman
20110 citationsauthor #3
Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals—correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels
201153 citationsauthor #2
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
2011141 citationsauthor #3
Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review
201119 citationsauthor #4
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
2010227 citationsauthor #1
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
201029 citationsauthor #5
Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
201075 citationsauthor #5
HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
2010302 citationsauthor #3
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
201071 citationsauthor #7
Combining the [2,3] Sigmatropic Rearrangement and Ring‐Closing Metathesis Strategies for the Synthesis of Spirocyclic Alkaloids. A Short and Efficient Route to (.+‐.)‐Perhydrohistrionicotoxin.
20100 citationsauthor #2
Difference in drug resistance patterns between minor HIV‐1 populations in cerebrospinal fluid and plasma
20099 citationsauthor #4
Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates
200916 citationsauthor #7
O4‐02‐08: Altered amyloid metabolism in neuroinflammation
20090 citationsauthor #4
Cerebrospinal fluid markers in the management of central nervous system HIV infection and the AIDS dementia complex.
20090 citationsauthor #2
Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
2009152 citationsauthor #8
CSF p-tau and Amyloid Beta 1-42 in HIV infection
20090 citationsauthor #4
Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes
20084 citationsauthor #2
Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy
2008118 citationsauthor #5
Pneumocystis jiroveci pneumonia in AIDS and other immunodeficiencies.
20070 citationsauthor #1
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
2007118 citationsauthor #2
Defining and Evaluating HIV-Related Neurodegenerative Disease and Its Treatment Targets: A Combinatorial Approach to Use of Cerebrospinal Fluid Molecular Biomarkers
200750 citationsauthor #2
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.
2007181 citationsauthor #5
[Neuroborreliosis with bad reputation. This is no mystical, difficult-to-treat infection!].
20070 citationsauthor #1
CSF neurofilament protein (NFL) — a marker of active HIV-related neurodegeneration
2007136 citationsauthor #5
Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.
200729 citationsauthor #4
Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia.
200610 citationsauthor #3
[Penicillin V is the first choice in the treatment of erythema migrans].
20060 citationsauthor #4
Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia – case report
200619 citationsauthor #2
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults
2006155 citationsauthor #10
Outcome of 8-hour dosing intervals with beta-lactam antibiotics in adult acute bacterial meningitis
20066 citationsauthor #2
Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study
200631 citationsauthor #3
An outbreak of diphtheria among Swedish alcoholics
200513 citationsauthor #4
Genetic factors in host resistance to urinary tract infection
200524 citationsauthor #3
Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis
2005100 citationsauthor #3
Cerebrospinal Fluid Viral Loads Reach Less than 2 Copies/ML in HIV-1-Infected Patients with Effective Antiretroviral Therapy
200541 citationsauthor #3
[Is neuroborreliosis as a cause of facial paralysis missed?].
20050 citationsauthor #1
CSF amyloid β42 and tau levels correlate with AIDS dementia complex
2005180 citationsauthor #5
A General Method for the Preparation of Chiral TREN Derivatives
200510 citationsauthor #4
Solid-phase synthesis of a 6-phenylquinolin-2(1H)-one library directed toward nuclear hormone receptors.
20053 citationsauthor #7
Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.
200552 citationsauthor #6

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT